![]() Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. | ![]() APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. | ![]() Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. | ![]() Instil Bio Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies. | ![]() Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. | ![]() Ohm Oncology Ohm Oncology is a drug development company committed to treating drug-resistant neoplasms and cancers with multi-mechanism compounds. | ||
Founding Date | Founding Date 2016 | Founding Date 2005 | Founding Date 2012 | Founding Date 2008 | Founding Date 2013 | Founding Date 2009 | Founding Date 2015 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||||
Locations | Locations London, GB HQ Stevenage, GB | Locations Wien, AT HQ | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Dallas, US HQ Dallas, US | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations Austin, US HQ |
Employees | Employees 695% decrease | Employees 5 | Employees 88 | Employees 1471% decrease | Employees 14868% increase | Employees 3,9671% decrease | Employees 167% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 223.8 m | Valuation ($) 3.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $263.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A | Cost of goods $173.2m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit £10.8m (FY, 2023) | Gross profit N/A | Gross profit $90.3m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($69.7m) (FY, 2023) | Net income N/A | Net income (£146m) (FY, 2023) | Net income ($71.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income N/A |
Operating ⚠ | |||||||
Office and Laboratory Space, square feet | Office and Laboratory Space, square feet 24.6 k (FY, 2020) | Office and Laboratory Space, square feet N/A | Office and Laboratory Space, square feet N/A | Office and Laboratory Space, square feet 131.3 k (Mar, 2021) | Office and Laboratory Space, square feet N/A | Office and Laboratory Space, square feet N/A | Office and Laboratory Space, square feet N/A |
Trademarks (US) | Trademarks (US) 3 (May, 2021) | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) N/A | Trademarks (US) 19 (Jan, 2024) | Trademarks (US) N/A |
Funding | |||||||
Total funding raised | Total funding raised $ 138.1m | Total funding raised N/A | Total funding raised $ 430.2m | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 85.3m | Total funding raised N/A |

APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.
View company
Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
View company
Instil Bio (formerly Immetacyte, Cellular Therapeutics) is an immuno-oncology company that specializes in cell therapies.
View company
Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
View company